The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 15, 2020

Filed:

Feb. 13, 2017
Applicant:

Children's Hospital Medical Center, Cincinnati, OH (US);

Inventors:

Gregory A. Grabowski, Wheat Ridge, CO (US);

Hong Du, Carmel, IN (US);

Assignee:

Children's Hospital Medical Center, Cincinnati, OH (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/20 (2006.01); A61K 38/46 (2006.01); A23L 33/18 (2016.01); A61K 48/00 (2006.01); C12N 7/00 (2006.01); A61K 9/00 (2006.01); A61K 38/18 (2006.01); A61K 38/40 (2006.01);
U.S. Cl.
CPC ...
A61K 38/465 (2013.01); A23L 33/18 (2016.08); A61K 9/0019 (2013.01); A61K 48/005 (2013.01); C12N 7/00 (2013.01); C12N 9/20 (2013.01); C12Y 301/01013 (2013.01); A61K 38/18 (2013.01); A61K 38/40 (2013.01); A61K 48/00 (2013.01); C12N 2799/021 (2013.01); C12N 2799/04 (2013.01);
Abstract

The present invention comprises a method to diminish and/or eliminate atherosclerotic plaques, in mammals, through direct and indirect treatment of these plaques, in situ, using suitable substances which are capable of lipid removal, primarily through hydrolysis, either by a catalytic or stoichiometric process, wherein the substance targets receptors in and/or on the cell which lead to uptake into the lysosome. Such substances used to diminish and/or eliminate atherosclerotic plaques are generally comprised of lipid hydrolyzing proteins and/or polypeptides.


Find Patent Forward Citations

Loading…